DIGESTIVE DISEASES AND SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2019-10-29 沉默者

已接受，要问的可以随便问

281 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2021-08-03 少年宁

1月6号投稿，5月20大修，8月3号接受！开心开心！

104 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2022-01-18 玄琳

为什么一直都是associated editor assigned

125 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2021-01-07 ms5000000552025461

今日刚投稿，希望能顺利！

170 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2022-07-16 ms6696835352756861

为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去

117 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2022-06-22 emilia77

偏重的研究方向：胰腺
经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。

71 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2019-11-07 伊利亚特

临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表::
请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表:
请问您是什么时候投的，是临床研究吗

453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗

195 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2022-05-17 ms5000001712628444

偏重的研究方向：消化
经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？

77 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2019-12-14 luobo198705051

好像不能共一和共通讯

202 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=579030, encodeId=51315e9030a0, content=已接受，要问的可以随便问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75ad2440307, createdName=沉默者, createdTime=Tue Oct 29 00:00:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004812, encodeId=56ac1004812ad, content=1月6号投稿，5月20大修，8月3号接受！开心开心！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Aug 03 07:06:44 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185480, encodeId=e3b81185480d7, content=为什么一直都是associated editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d375574557, createdName=玄琳, createdTime=Tue Jan 18 07:36:29 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914533, encodeId=ff6991453392, content=今日刚投稿，希望能顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=ms5000000552025461, createdTime=Thu Jan 07 22:53:01 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232825, encodeId=61c7123282525, content=为什么一定要提供单位邮箱，单位没有单位邮箱，一直来来回回要，无法投稿出去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5a1747964, createdName=ms6696835352756861, createdTime=Sat Jul 16 17:39:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227893, encodeId=a911122e893fd, content=偏重的研究方向：胰腺 经验分享：一审大概2月，大修后，二审7天，接收。还是挺快的，不要版面费的杂志，还是不错的选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Wed Jun 22 07:15:39 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579469, encodeId=fc455e9469f2, content=临床研究，翻我前面的留言，有时间轴，从投稿到接收不满两个月，今天刚online453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗453544759 2019-11-04 00:00:00 发表: 请问您是什么时候投的，是临床研究吗, beContent=453544759 2019-11-04 发表:: 请问您是什么时候投的，是临床研究吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/e25d2604eccebad31f0e1363efd3f53d.jpg, createdBy=debc2479590, createdName=伊利亚特, createdTime=Thu Nov 07 00:00:00 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220492, encodeId=316b12204925a, content=偏重的研究方向：消化 经验分享：associate editor invited已经20天，求问有经验的老师这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Tue May 17 17:43:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581499, encodeId=43e5581499d5, content=好像不能共一和共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee1e1457165, createdName=luobo198705051, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238024, encodeId=95511238024f3, content=审稿速度:1.0 偏重的研究方向：回顾性临床研究 经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ef75693246, createdName=ms7000000170612940, createdTime=Thu Aug 11 10:01:53 CST 2022, time=2022-08-11, status=1, ipAttribution=)]

2022-08-11 ms7000000170612940

审稿速度:1.0
偏重的研究方向：回顾性临床研究
经验分享：投稿22天，没有评审理由被拒，decision in progress了四天，可能在纠结要不要直接拒，最后还是拒了，唉

75 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务